Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Chinese Journal of Hospital Pharmacy》 2009-03
Add to Favorite Get Latest Update

Clinical evaluation of therapeutic methods on advanced stage lung cancer in shanghai area inrecent ten years

SHI Yi1,LI Yong1,CHEN Shi-wei1,XU Feng1,WANG Hai-ping1,FANG Ding-zhu2(1.Oncology Department,Shanghai Pudong New Area Gongli Hospital,Shanghai 200135,China;2.Pediatrics Department,Xinhua Hospital,Shanghai 200092,China)  
OBJECTIVE To study the current status of therapeutic methods and evaluate the therapeutic effect by investigating and analyzing the clinical information on advanced stage lung cancer in Shanghai during recent ten years.To explore the means and value of treatment in the area high incidence of lung cancer.METHODS To review clinical data of more than 70 literatures and 2 904 cases published in domestic medicine journal about the therapeutic methods and effect on advanced stage lung cancer in Shanghai area.The results were analyzed by SPSS software.RESULTS Single treatment was main method for advanced lung cancer.The first was Chinese traditional medicine then following interventional therapy and vein chemotherapy respectively.The main means was two methods combined in multidisciplinary therapy.The effective rate was up to 37.9% and 54.1% in single therapy and multidisciplinary therapy respectively.Both heteropathy and interventional therapy had the higher effective rate 57.7% in single therapy and 76.7% in multidisciplinary therapy respectively.CONCLUSION To combine appropriately different methods can enhance effective rate for advanced stage lunge cancer and make sure that multidisciplinary therapy is more excel single therapy.The clinical information on late stage lung cancer in shanghai has some representative meaning and will guide to such treatment.
【Key Words】: advanced stage lung cancer multidisciplinary therapy clinical evaluation
【Fund】: 上海浦东新区科技发展基金创新基金(编号:NO.PKJ2006_Y18)
【CateGory Index】: R734.2
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
【Citations】
Chinese Journal Full-text Database 1 Hits
1 MA Wang-kou,XU Yun-long,XING Guang-fu,et al(Department of Surgery,Shanghai 8th Hospital,Shanghai 200233,China);Combined therapy based on palliative resection,implantation of ~(125)I seeds,thermotherapy and chemotherapy for advanced lung cancer[J];Chinese Journal of Clinical Oncology and Rehabilitation;2005-01
【Co-references】
Chinese Journal Full-text Database 9 Hits
1 MIAO Li-qiong, LI Jiang-ling, WU Yun-kun, et al. The People′s Hospital of Yuxi City, Yunnan, 653100;Analysis of medical expenses of the systematic diseases in order inpatients proportions with factor method[J];Chinese Journal of Hospital Statistics;2006-01
2 WANG Mei,WANG Yuan-yuan, GUO Bin, et al. China National Heath Economics Institute, MOH, Beijing, 100083,China;Status Quo and Issues of Direct Impatient Cost of Lung Carcinoma in China[J];Chinese Health Economics;2007-06
3 LIU Guo-en,TANG Yan First-author’s address China Center for Pharmacoeconomics & Outcomes Research,Peking University,Beijing,100871,China;Trend Analysis of Drug Expenditure in China[J];Chinese Health Economics;2007-12
4 LEI Yali,LI Daiqiang (Department of Pathology,Second Xiangya Hospital,Central South University,Changsha 410011,China);Advances of epidermal growth factor receptor and targeted therapy for non-small-cell lung cancer[J];International Journal of Pathology and Clinical Medicine;2009-01
5 LI Wu-ping,SONG Qi-ru,DAI Xiu-ying,et al (School of Public Health,Ningxia Med.Univ.,Yinchuan 750004);The Impact of Druge Purchase by Public Bidding on Medical Expenses of Insurance and Self-paid In-patients in Ningxia[J];Journal of Ningxia Medical University;2009-06
6 WANG Lin,YANG Ning-rong,QIAN Jun,CHEN Ying-xia,WANG Feng,QIN Shu-kui(Department of Medical Oncology,PLA Oncology Center of the 81st Hospital,Nanjing Jiangsu,210002);Evaluations of advanced non-small cell lung cancer patients treated with erlotnib[J];Journal of Clinical Medicine in Practice;2009-07
7 LI Tai-dong NI Wu LIN Yu-chao (The Central Hospital of Guangdong Province Agricultural Reclamation,Zhanjiang,524002,China);Observation on efficacy of GP neoadjuvant chemotherapy plus surgery in treatment of stage-Ⅲ non-small cell lung cancer[J];Chinese Journal of Clinical Oncology and Rehabilitation;2008-06
8 ZHOU Min,XU Tie-zhen,QIU Yan-jun;An Analysis of Neo-adjuvant Chemotherapy and Operation for 78 Cases with Non-small Cell Lung Cancer Stage Ⅲ[J];China Cancer;2008-07
9 XU Ai-hui, YINYan-wei, CHEN Fei-hu. Department of Respiratory Medicine, Affiliated Hospital of Anhui Medical University, Hefei 230032, China;The value of serum endostatin level in early diagnosis of lung cancer[J];National Medical Journal of China;2006-27
【Secondary Citations】
Chinese Journal Full-text Database 3 Hits
1 NIU Hong mei,LIU Jia xiang (Shanghai University of TCM,Shanghai 200032);Research on the Mechanisms of TCM Acting on the Inhibition of Tumor Metastasis[J];Liaoning Journal of Traditional Chinese Medicine;2002-04
2 SHI Yuankai, PAN Feng, HAN Xiaohong, et al. Department of Medical Oncology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021;Combination of high dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high risk breast cancer: a pilot study[J];NATIONAL MEDICAL JOURNAL OF CHINA;1999-12
3 ZHA Aiqin, GUO Genfa (Zhejiang Cancer Hospital, Hangzhou 310022 , P.R. China);Advanced Nonsmall cell lung cancer treatment with Vinorelbine, Docetaxel, Gemcitabine combined with Cisplatine, respectly: a report of 95 patients[J];Tumor;2002-02
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved